440 related articles for article (PubMed ID: 28377530)
1. Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion.
Luthra P; Aguirre S; Yen BC; Pietzsch CA; Sanchez-Aparicio MT; Tigabu B; Morlock LK; García-Sastre A; Leung DW; Williams NS; Fernandez-Sesma A; Bukreyev A; Basler CF
mBio; 2017 Apr; 8(2):. PubMed ID: 28377530
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
[TBL] [Abstract][Full Text] [Related]
3. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
4. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
6. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
Fanunza E; Frau A; Corona A; Tramontano E
Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
[TBL] [Abstract][Full Text] [Related]
7. The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.
Bharaj P; Atkins C; Luthra P; Giraldo MI; Dawes BE; Miorin L; Johnson JR; Krogan NJ; Basler CF; Freiberg AN; Rajsbaum R
J Virol; 2017 Sep; 91(18):. PubMed ID: 28679761
[TBL] [Abstract][Full Text] [Related]
8. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
9. Duck Enteritis Virus Inhibits the cGAS-STING DNA-Sensing Pathway To Evade the Innate Immune Response.
Gao L; Liu R; Yang F; Li X; Liu C; Qi X; Cui H; Zhang Y; Wang S; Wang X; Gao Y; Li K
J Virol; 2022 Dec; 96(24):e0157822. PubMed ID: 36448809
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
[TBL] [Abstract][Full Text] [Related]
11. Tetherin Inhibits Nipah Virus but Not Ebola Virus Replication in Fruit Bat Cells.
Hoffmann M; Nehlmeier I; Brinkmann C; Krähling V; Behner L; Moldenhauer AS; Krüger N; Nehls J; Schindler M; Hoenen T; Maisner A; Becker S; Pöhlmann S
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429347
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation.
Yen B; Mulder LC; Martinez O; Basler CF
J Virol; 2014 Nov; 88(21):12500-10. PubMed ID: 25142601
[TBL] [Abstract][Full Text] [Related]
13. Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.
Leung LW; Park MS; Martinez O; Valmas C; López CB; Basler CF
Immunol Cell Biol; 2011 Oct; 89(7):792-802. PubMed ID: 21263462
[TBL] [Abstract][Full Text] [Related]
14. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice.
Vasou A; Paulus C; Narloch J; Gage ZO; Rameix-Welti MA; Eléouët JF; Nevels M; Randall RE; Adamson CS
Antiviral Res; 2018 Feb; 150():79-92. PubMed ID: 29037975
[TBL] [Abstract][Full Text] [Related]
15. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
16. Caspase-Mediated Regulation and Cellular Heterogeneity of the cGAS/STING Pathway in Kaposi's Sarcoma-Associated Herpesvirus Infection.
Tabtieng T; Lent RC; Kaku M; Monago Sanchez A; Gaglia MM
mBio; 2022 Dec; 13(6):e0244622. PubMed ID: 36255240
[TBL] [Abstract][Full Text] [Related]
17. Filoviral immune evasion mechanisms.
Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
[TBL] [Abstract][Full Text] [Related]
18. Innate immune evasion by filoviruses.
Basler CF
Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
[TBL] [Abstract][Full Text] [Related]
19. Unabated adenovirus replication following activation of the cGAS/STING-dependent antiviral response in human cells.
Lam E; Falck-Pedersen E
J Virol; 2014 Dec; 88(24):14426-39. PubMed ID: 25297994
[TBL] [Abstract][Full Text] [Related]
20. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]